Table 2.
Unadjusted and adjusted means of flow-mediated dilation (FMD) measures (dependentvariable) according to different treatments.
Characteristics |
Nutraceutical A (n=24) |
Nutraceutical B (n=23) |
p |
---|---|---|---|
Baseline | 5.19 ± 2.25 | 4.74 ± 1.67 | 0.14 |
| |||
Follow-up (unadjusted) | 7.55 ± 3.38 | 5.75 ± 2.09 | 0.04 |
Follow up (adjusted) ∗ | 7.48 ± 0.58 | 5.58 ± 0.59 | 0.05 |
∗ ANCOVA: analysis adjusted for age, gender, and baseline value.